White Light vs Narrow Band Imagingin the Diagnosis of Right Sided Colonic Polyps in Asymptomatic Subjects Undergoing Screening Colonoscopy

NARECRUITING

A randomized controlled crossover study to determine if narrow band imaging or white light endoscopy is superior in detecting right colonic polyps in average risk subjects undergoing screening colonoscopy.

Study details:

Removal of colorectal adenomas prevents occurrence of cancers. It is recognized that colonoscopy can miss colorectal adenomas and early cancers. Proximal colon polyp detection rate is lower compared to distal colon detection rates.

This may be partially due to the higher prevalence of flat polyps and sessile serrated adenomas (SSAs) which are harder to visualize. There is a need to further improve performance of colonoscopy. A second evaluation of the right colon within the same procedure may yield an additional detection rate of 5-10%, however retro-flexion has not proven to be superior to a second forward viewing examination.

The use of chromo-endoscopy has been shown to improve detection of flat adenomas. Narrow band imaging was introduced in year 2006. It is similar to chromo-endoscopy in that it provides more mucosal details.

This enables endoscopists to accurately describe the pit pattern of adenomas. NBI has been used as a substitute to chromo-endoscopy. In pooled analysis, NBI is comparable to chromo-endoscopy in their sensitivity and specificity in the diagnosis of malignant colorectal adenomas.

Unfortunately, the use of NBI has not been shown to conclusively improve rate of colorectal adenoma detection. Two of 3 randomized trials that compared WLE to NBI showed a higher adenoma detection rate with the use of NBI. In a study by Rex et al.

, the rate was however similar with either modality. In a pooled analysis, NBI was only marginally better than WLE. The effective use of NBI depends on the quality of bowel preparation and the experience of endoscopist.

In the presence of fecal matters, NBI tends to be dark and detection of small adenomas becomes difficult. The prototype bright NBI coupled with high definition resolution is likely to overcome this drawback of original NBI.

Eligibility criteria

Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.

Inclusion criteria

  1. Asymptomatic subjects undergoing screening colonoscopy
  2. age > 50
  3. average risk subjects defined as those without a personal history of inflammatory bowel disease, colon adenoma or cancer or family history of FAP or Familial non-polyposis syndrome or first degree relatives having diagnosed to have colo-rectal carcinoma, no colonoscopy in past 5 years and, ability to provide a written consent to trial participation

Exclusion criteria

  1. unable to consent

Eligibility

Age eligible for study : NA

Healthy volunteers accepted : No

Gender eligible for study: ALL

Things to know

Study dates

Study start:

Primary completion:

Study completion finish:

study type

Study type

DIAGNOSTIC

phase

Phase

    NA

trial

Study ID

NCT05935124

Intervention or treatment

DIAGNOSTIC_TEST: WLE first, then B-NBI

Conditions

  • Adenoma Colon
  • Condition: Adenoma Colon

  • DIAGNOSTIC_TEST: WLE first, then B-NBI

  • Sydney, New South Wales, Australia

  • Sponsor: Western Sydney Local Health District

You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.

Are you running this trial?

If you're a clinic or sponsor, you can claim this study

Research sites nearby

Closest Location:

Westmead Hospital

Select from list below to view details:

  • Westmead Hospital

    Sydney, New South Wales, Australia

Loading map...

Who is running the clinical trial?

WSLHD

Western Sydney Local Health District

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Participant Group/ArmIntervention/Treatment
OTHER: First withdrawal - White light endoscopy
  • white light (WLE) high definition colonoscope (Olympus 190 series) first and then B-NBI
Diagnostic Test: WLE first, then B-NBI
    OTHER: First withdrawal - Bright Narrow Band Imagin
    • B-NBI first and then WLE with the same colonoscope.
    Diagnostic Test: WLE first, then B-NBI

      What is the study measuring?

      Primary Outcome

      MeasureDescriptionTime Frame
      Rate of right sided polyp detection with WLE and B-NBINot Specified1 day

      Secondary Outcome

      MeasureDescriptionTime Frame
      Rate of the detection of SSPs in the right colon with WLE and B-NBINot Specified1 day
      Are you running this trial?If you're a clinic or sponsor, you can claim this study.

      References

      Clinical Trials Gov: White Light vs Narrow Band Imagingin the Diagnosis of Right Sided Colonic Polyps in Asymptomatic Subjects Undergoing Screening Colonoscopy

      Other trials to consider

      Loading suggested trials...

      Top searched conditions